Search results

Order by most recent / most popular / relevance

Results: 1-10 of 36

Isolated genes no longer patentable: Supreme Court reverses Federal Circuit in Myriad case

Sutherland Asbill & Brennan LLP
-
USA
-
June 13 2013

In a thinly worded unanimous decision in Assn. For Molecular Pathology v. Myriad Genetics, Inc. on June 13, 2013, the U.S. Supreme Court held that

Monsanto ruling protects innovators of self-replicating biotechnology

Sutherland Asbill & Brennan LLP
-
USA
-
May 14 2013

On May 13, 2013, a unanimous U.S. Supreme Court held in Monsanto v. Bowman that the doctrine of patent exhaustion does not permit a farmer to

A new design patent international filing treaty

Sutherland Asbill & Brennan LLP
-
USA
-
January 4 2013

A new system for international design patent registration will greatly benefit design innovators through cost and timing efficiencies. In December 2012

MagLite asserts design patent

Sutherland Asbill & Brennan LLP
-
USA
-
January 10 2012

Mag Instrument, Inc., the maker of MagLite flashlight products, filed a complaint for design patent infringement against the National Rifle Association and Does 1-10 in the U.S. District Court for the Central District of California

Isolated DNA molecules are patentable chemical entities, and patent-eligible diagnostic methods must include transformational steps

Sutherland Asbill & Brennan LLP
-
USA
-
August 2 2011

In a vindicating win for the biotechnology industry, the Court of Appeals for the Federal Circuit in Assoc. for Molecular Pathology v. Myriad Genetics, Inc. (Fed. Cir. No. 2010-1406) on July 29, 2011, reversed the lower court and held that “isolated” DNA, including genes and sequence-specific probes for detecting breast and ovarian cancer, are patent-eligible subject matter, since these molecules are “markedly different” new chemical entities that do not exist in nature

Shredding before suing? Think twice (update)

Sutherland Asbill & Brennan LLP
-
USA
-
June 2 2011

Patent owners are now on notice: The Federal Circuit has confirmed that shredding relevant documents after identifying litigation targets can lead to spoliation sanctions, even if the destruction occurred before litigation was "imminent" or "probable without significant contingencies."

Ashbury International Group sues competitor for patent infringement

Sutherland Asbill & Brennan LLP
-
USA
-
January 10 2012

Ashbury International Group, Inc. filed a complaint against Cadex Defence, Inc., and Drake Associates, Inc., for patent infringement of U.S. Patent Number 7,802,392

Lavagear heats up the competition

Sutherland Asbill & Brennan LLP
-
USA
-
October 3 2011

Patent litigation filed by Lavagear Inc. against two manufacturers and three retailers involves U.S. Patent No. 6,598,235

A little rule with big implications: USPTO implements new fee schedule including a 75 reduction in patent fees for applicants qualifying for "micro entity" status

Sutherland Asbill & Brennan LLP
-
USA
-
March 28 2013

On March 19, 2013, the United States Patent and Trademark Office (USPTO) implemented a new fee schedule as authorized by the Leahy-Smith America

LaserMax granted royalty-free patent licenses in crimson trace patent infringement feud

Sutherland Asbill & Brennan LLP
-
USA
-
February 10 2011

LaserMax, Inc. (“LaserMax”) and Crimson Trace Corp. (“Crimson Trace”) recently settled a patent infringement case filed in January 2009 related to four patents for laser sighting devices for firearms asserted by Crimson Trace

next >